Lack of JunD promotes pressure overload-induced apoptosis, hypertrophic growth, and angiogenesis in the heart

被引:57
|
作者
Hilfiker-Kleiner, D
Hilfiker, A
Kaminski, K
Schaefer, A
Park, JK
Michel, K
Quint, A
Yaniv, M
Weitzman, JB
Drexler, H
机构
[1] Hannover Med Sch, Dept Cardiol & Angiol, Hannover, Germany
[2] Hannover Med Sch, Dept Cardiovasc Surg, Hannover, Germany
[3] Hannover Med Sch, Dept Nephrol, Hannover, Germany
[4] Inst Pasteur, Unit Gene Express & Dis, Paris, France
关键词
angiogenesis; apoptosis; hypertrophy;
D O I
10.1161/CIRCULATIONAHA.104.518472
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background - The Jun family of activator protein 1 (AP-1) transcription factors (c-Jun, JunB, and JunD) is involved in fundamental biological processes such as proliferation, apoptosis, tumor angiogenesis, and hypertrophy. The role of individual AP-1 transcription factors in the stressed heart is not clear. In the present study we analyzed the role of JunD in survival, hypertrophy, and angiogenesis in the pressure-overloaded mouse heart after thoracic aortic constriction. Methods and Results - Mice lacking JunD (knockout [KO]) showed increased mortality and enhanced cardiomyocyte apoptosis and fibrosis associated with increased levels of hypoxia-induced factor-1 alpha, vascular endothelial growth factor (VEGF), p53, and Bax protein and reduced levels of Bcl-2 protein after 7 days of severe pressure overload compared with wild-type (WT) siblings. Cardiomyocyte hypertrophy in surviving KO mice was enhanced compared with that in WT mice. Chronic moderate pressure overload for 12 weeks caused enhanced left ventricular hypertrophy in KO mice, and survival and interstitial fibrosis were comparable with WT mice. Cardiac function, 12 weeks after operation, was comparable among shams and pressure-overloaded mice of both genotypes. In addition, KO mice exposed to chronic pressure overload showed higher cardiac capillary density associated with increased protein levels of VEGF. Conclusions - Thus, JunD limits cardiomyocyte hypertrophy and protects the pressure-overloaded heart from cardiac apoptosis. These beneficial effects of JunD, however, are associated with antiangiogenic properties.
引用
收藏
页码:1470 / 1477
页数:8
相关论文
共 50 条
  • [21] Cardiac Microvascular Endothelial Cells in Pressure Overload-induced Heart Disease (*)
    Trenson, Sander
    Carmeliet, Peter
    de Zeeuw, Pauline
    Ghesquiere, Bart
    Goetschalckx, Kaatje
    Herijgers, Paul
    Hermans, Hadewich
    Herregods, Marie-Christine
    Janssens, Stefan
    Luttun, Aernout
    Meuris, Bart
    Meyns, Bart
    Oosterlinck, Wouter
    Pokreisz, Peter
    Rega, Filip
    Voigt, Jens-Uwe
    ACTA CARDIOLOGICA, 2020, 75 : 16 - 17
  • [22] CXCL10 regulates pressure overload-induced heart failure
    Souza-Neto, Fernando
    Le, Preston
    Alamgir, Ashab
    van Berlo, Jop H.
    PHYSIOLOGY, 2024, 39
  • [23] Disruption of sarcalumenin accelerated pressure overload-induced heart failure in mice
    Shimura, M
    Minamisawa, S
    Takeshima, H
    Umemura, S
    Ishikawa, Y
    CIRCULATION, 2005, 112 (17) : U67 - U67
  • [24] The role of DPP-4 in pressure overload-induced heart failure
    Hirose, M.
    Takako, H.
    Hasegawa, H.
    Kobara, Y.
    Tadokoro, H.
    Takemura, G.
    Kobayashi, Y.
    EUROPEAN HEART JOURNAL, 2016, 37 : 1330 - 1330
  • [25] Reduction in Glucocorticoid Receptor Expression Attenuates Pressure Overload-induced Cardiac Hypertrophy and Promotes Heart Failure in Mice
    Wu, Rongxue
    Knapp, Maura
    Zheng, Mei
    Liao, James K.
    CIRCULATION RESEARCH, 2016, 119
  • [26] Compartment of protein kinases and phosphoprotein phosphorases in pressure overload-induced hypertrophic rat hearts
    Liu, J
    Wang, PY
    He, ZY
    Xiao, YB
    CIRCULATION RESEARCH, 2005, 97 (02) : E13 - E13
  • [27] Loss of Endogenous HMGB2 Promotes Cardiac Dysfunction and Pressure Overload-Induced Heart Failure in Mice
    Sato, Michio
    Miyata, Keishi
    Tian, Zhe
    Kadomatsu, Tsuyoshi
    Ujihara, Yoshihiro
    Morinaga, Jun
    Horiguchi, Haruki
    Endo, Motoyoshi
    Zhao, Jiabin
    Zhu, Shunshun
    Sugizaki, Taichi
    Igata, Kimihiro
    Muramatsu, Masashi
    Minami, Takashi
    Ito, Takashi
    Bianchi, Marco E.
    Mohri, Satoshi
    Araki, Kimi
    Node, Koichi
    Oike, Yuichi
    CIRCULATION JOURNAL, 2019, 83 (02) : 368 - +
  • [28] Calpain activation is involved in the pressure overload-induced hypertrophy in the mouse heart
    Fukunaga, K
    Hashimoto, M
    Shioda, N
    Hachimura, E
    Shirasaki, Y
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 97 : 136P - 136P
  • [29] Aliskiren ameliorates pressure overload-induced heart hypertrophy and fibrosis in mice
    Li-qing Weng
    Wen-bin Zhang
    Yong Ye
    Pei-pei Yin
    Jie Yuan
    Xing-xu Wang
    Le Kang
    Sha-sha Jiang
    Jie-yun You
    Jian Wu
    Hui Gong
    Jun-bo Ge
    Yun-zeng Zou
    Acta Pharmacologica Sinica, 2014, 35 : 1005 - 1014
  • [30] Protective effect of resveratrol against pressure overload-induced heart failure
    Gupta, Prakash K.
    DiPette, Donald J.
    Supowit, Scott C.
    FOOD SCIENCE & NUTRITION, 2014, 2 (03): : 218 - 229